Michael J. Reardon
Michael J. Reardon is an American cardiac surgeon and medical researcher. He is known for his work in heart autotransplantation for malignant heart tumors, an operation in which the surgeon removes the patient's heart, cuts out the malignant tumor, and reimplants the heart back in the patient's chest. He performed the first successful heart autotransplantation for a cancerous heart tumor in 1998.Dr. Reardon has served as a leading clinical investigator in the trans-catheter aortic valve replacement (TAVR) field. He serves as the national surgical principal investigator for the Evolut intermediate-risk trial (SURTAVI, NCT01586910), the Evolut low-risk trial (NCT02701283), the Evolut 34 mm trial (NCT02746809), the Evolut 2.0 trial (NCT02738853), the Reprise III Lotus high and extreme risk trial (NCT02202434), the Acurate trial (NCT03735667), the Portico NG trial (NCT04011722) and the Vantage trial (NCT04788888). He serves as a national study chair for the Reprove IV trial (NCT03618095) and the Evolut low-risk bicuspid trial (NCT03635424). Provided by Wikipedia
Showing 1 - 16 results of 16 for search 'Michael J. Reardon', query time: 0.02s
Refine Results
-
1
Commentary: Opportunity is like a sunrise. If you wait too long, you miss itCentral Message by Michael J. Reardon, MD
Published 2021-12-01Get full text
Article -
2
Commentary: Right atrium/inferior vena cava junction—the meeting placeCentral Message by Michael J. Reardon, MD
Published 2022-02-01Get full text
Article -
3
Commentary: Robotic resection of a primary cardiac sarcoma: When the stars alignCentral Message by Michael J. Reardon, MD
Published 2020-06-01Get full text
Article -
4
Transcatheter Mitral Valve Replacement with Dedicated Devices by Joe Aoun, Michael J. Reardon, Sachin S. Goel
Published 2023-05-01Get full text
Article -
5
Commentary: There's more than one way to skin a cat (thoraco)Central Message by Marvin D. Atkins, MD, Michael J. Reardon, MD
Published 2021-06-01Get full text
Article -
6
Endovascular Management of the Ascending Aorta: State of the Art by Aidan D. Atkins, Michael J. Reardon, Marvin D. Atkins
Published 2023-03-01Get full text
Article -
7
-
8
Commentary: Trim the fatCentral Message by Thomas E. MacGillivray, MD, Michael J. Reardon, MD
Published 2022-02-01Get full text
Article -
9
-
10
Transcatheter Aortic Valve Implantation: Long-Term Outcomes and Durability by Parth V. Desai, Sachin S. Goel, Neal S. Kleiman, Michael J. Reardon
Published 2023-05-01Get full text
Article -
11
What’s New with TAVR? An Update on Device Technology by Syed Zaid, Marvin D. Atkins, Neal S. Kleiman, Michael J. Reardon, Gilbert H. L. Tang
Published 2023-05-01Get full text
Article -
12
-
13
-
14
-
15
Uniform Safety and Excellent Performance of Pressure-Regulated Deployment of Transcatheter Aortic Valves by Afik Snir, MBBS, BE, Michael K. Wilson, MBBS, Bianca Coelho, BSc, Andrew Moussad, MBBS, Christopher Naoum, MBBS, PhD, Stephen G. Worthley, MBBS, PhD, Michael J. Reardon, MD, David S. Celermajer, MBBS, PhD, Martin K. Ng, MBBS, PhD
Published 2025-09-01Get full text
Article -
16
Mitral Transcatheter Edge-to-Edge Repair In-Hospital Outcomes and Mitral Valve Surgery Readmission Trends: National Readmission Database 2018-2020 by Abdul Rahman Akkawi, MD, Syed Zaid, MD, Taha Hatab, MD, Rody G. Bou Chaaya, MD, Emmanuel Oundo, MD, Nadeen Faza, MD, Stephen H. Little, MD, Marvin D. Atkins, MD, Michael J. Reardon, MD, William A. Zoghbi, MD, Neal S. Kleiman, MD, Sachin S. Goel, MD
Published 2025-02-01Get full text
Article